NCT02512874

Brief Summary

Frailty is a state of health with predisposition to adverse events, morbidity and mortality. Frailty consists of weakness, slowness, low physical activity, exhaustion, and wasting. Frailty is associated with increased hospitalizations and death in lung disease. It is unknown if pulmonary rehabilitation will improve frailty markers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 21, 2015

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

July 24, 2015

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 31, 2015

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

October 5, 2018

Completed
11 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2018

Completed
Last Updated

June 23, 2020

Status Verified

June 1, 2020

Enrollment Period

3.2 years

First QC Date

July 24, 2015

Results QC Date

August 30, 2018

Last Update Submit

June 10, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Frailty Phenotype at Baseline and 6 Months

    Frailty phenotype is 3 or more of: slow gait speed, exhaustion, decreased hand grip strength, decreased activity level, or wasting. Grip strength parameters, gait speed, exhaustion per Fried et al. 2001. Wasting is defined as further decrease in fat free mass by body composition measurement using DEXA. Low physical activity would be activity monitor in lower quartile.

    Baseline, Six months

Secondary Outcomes (5)

  • Wasting

    after pulmonary rehabilation completion, appoximately 8 weeks

  • Change in Strength

    after completion of pulmonary rehab, approximately 8 weeks

  • Change in Gait Speed

    pre and post pulmonary rehab, approximately 8 weeks

  • Improvement in Exhaustion

    pre and post pulmonary rehab, approximately 8 weeks

  • Change in Physical Activity Level

    pre and post pulmonary rehab, approximately 8 weeks

Study Arms (1)

Pulmonary Rehabilitation

OTHER

One arm study - all participants will go to pulmonary rehabilitation, received questionnaires, Dual-energy X-ray absorptiometry (DEXA) scans, Dynamometer and gait speed tests and activity measured through an activity monitor.

Other: Pulmonary RehabilitationDevice: DynamometerRadiation: DEXAOther: Gait Speed TestDevice: Activity MonitorOther: Questionnaires

Interventions

Measures of frailty taken before and after pulmonary rehabilitation.

Pulmonary Rehabilitation

Grip Test

Pulmonary Rehabilitation
DEXARADIATION

Body Composition Testing

Pulmonary Rehabilitation

15 foot walk test

Pulmonary Rehabilitation

Measures energy expenditure and activity

Pulmonary Rehabilitation

Health-related questionnaires measuring self-reported exhaustion, emotions and disease symptoms.

Pulmonary Rehabilitation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Referred for pulmonary rehabilitation
  • consenting to research

You may not qualify if:

  • Under 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

Related Links

MeSH Terms

Conditions

Lung Diseases

Interventions

Muscle Strength DynamometerFitness TrackersSurveys and Questionnaires

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diagnostic EquipmentEquipment and SuppliesWearable Electronic DevicesElectrical Equipment and SuppliesData CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Results Point of Contact

Title
Dr. Cassie C. Kennedy
Organization
Mayo Clinic

Study Officials

  • Cassie Kennedy, MD

    Mayo Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant for Critical Care Medicine

Study Record Dates

First Submitted

July 24, 2015

First Posted

July 31, 2015

Study Start

July 21, 2015

Primary Completion

October 16, 2018

Study Completion

October 16, 2018

Last Updated

June 23, 2020

Results First Posted

October 5, 2018

Record last verified: 2020-06

Locations